Drug profile

The FDA adverse-event record for Intravenous Fluids

282 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Intravenous Fluids. See the species affected, top reactions, and outcomes below.

282
adverse-event reports
36.5%
death-coded share
Dog
most-reported species
82
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
282
Total Reports
103
Deaths Reported
36.5%
Death Rate

Active Ingredients

Intravenous Fluids

Administration Routes

IntravenousUnknown

Species Affected

Dog 205
Cat 74
Cougar 1
Lynx 1
Pig 1

Most Affected Breeds

Domestic Shorthair 49
Retriever - Labrador 22
Terrier - Bull - American Pit 12
Chihuahua 10
Retriever - Golden 10
Bulldog - French 10
Boxer (German Boxer) 9
Terrier - Yorkshire 8
Crossbred Canine/dog 8
Shih Tzu 8

Most Reported Reactions

Vomiting 82
Lethargy (see also Central nervous system depression in 'Neurological') 58
Anorexia 57
Death by euthanasia 56
Lethargy (see also Central nervous system depression in Neurological) 48
Diarrhoea 47
Death 47
Other abnormal test result NOS 37
Ataxia 37
Weight loss 33
Fever 31
Elevated blood urea nitrogen (BUN) 31

Outcome Breakdown

Ongoing
81 (28.7%)
Euthanized
56 (19.9%)
Recovered/Normal
54 (19.1%)
Died
47 (16.7%)
Outcome Unknown
43 (15.2%)
Recovered with Sequela
1 (0.4%)

Intravenous Fluids Adverse Event Insights

282 reports name Intravenous Fluids; 103 recorded a death outcome (36.5% of reported events, not a population-level mortality rate). Active ingredient: Intravenous Fluids. Administration routes: Intravenous, Unknown.

By species: Dog (205 reports), Cat (74 reports), Cougar (1 reports). By breed: Domestic Shorthair (49), Retriever - Labrador (22), Terrier - Bull - American Pit (12).

Leading clinical signs: Vomiting (82), Lethargy (see also Central nervous system depression in 'Neurological') (58), Anorexia (57), Death by euthanasia (56). Outcome, 282 coded reports: Ongoing leads at 28.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.